Drug · DIN 01997602
DANTRIUM CAPSULES
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 27, 2026; first marketed December 31, 1993.
- Drug Identification Number (DIN)
- 01997602
- Company (DIN owner)
- Knight Therapeutics Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Dantrolene M03CA01
- Class
- Human
- Record last updated
- January 28, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DANTROLENE SODIUM | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 27, 2026: NOC 36789New Drug Submission (NDS) · Administrative: Change in product ownership
- August 1, 2024: NOC 33741New Drug Submission (NDS) · Administrative: Change in product ownership
- March 12, 2015: NOC 16684New Drug Submission (NDS) · Manufacturer name change
- January 21, 2015: NOC 16551New Drug Submission (NDS) · Merger - buyout
- December 18, 2008: NOC 9945New Drug Submission (NDS) · Manufacturer name change
Other DINs named DANTRIUM CAPSULES
- DIN 01997653 · Cancelled Post Market